News
CMND
5.40
-3.29%
-0.18
Weekly Report: what happened at CMND last week (1026-1030)?
Weekly Report · 11/02 09:31
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 10/30 12:05
Psychedelic: Clearmind completes recruitment for AUD cohort of CMND-100 trial
TipRanks · 10/29 14:00
Clearmind Advances CMND-100 Into Patient Testing For Alcohol Use Disorder; Stock Down
NASDAQ · 10/27 14:44
Clearmind completes patient recruitment for AUD cohort of CMND-100 trial
TipRanks · 10/27 13:14
Clearmind Medicine Completes Participant Recruitment For First Segment Of Part B Of Its Phase I/IIa Clinical Study Of CMND-100 To Treat Alcohol Use Disorder
Benzinga · 10/27 12:23
Weekly Report: what happened at CMND last week (1019-1023)?
Weekly Report · 10/26 09:31
Weekly Report: what happened at CMND last week (1012-1016)?
Weekly Report · 10/19 09:31
Clearmind Medicine’s Charging Robotics launches robotaxi charging platform
TipRanks · 10/12 13:15
Clearmind Medicine's Charging Robotics Subsidiary Rolls Out Autonomous Vehicle Charging Platform
Benzinga · 10/12 11:56
Weekly Report: what happened at CMND last week (1005-1009)?
Weekly Report · 10/12 09:33
Clearmind Gains Japan Patent Coverage For 3-MMC And PEA Combination
NASDAQ · 10/08 17:51
Clearmind Medicine publishes patent application in Japan for treating dyskinesia
TipRanks · 10/08 11:40
Clearmind Medicine Publishes Patient Application In Japan For Its Compositions And Methods For Treating Dyskinesia
Benzinga · 10/08 11:33
Clearmind Announces Patent Publication in Japan Covering Treatment for Neurological Movement Disorder
Barchart · 10/08 06:32
Clearmind Medicine submits psychedelic therapy recommendations to FDA
TipRanks · 10/07 13:25
Clearmind Advances Dialogue with U.S. Federal Government on Psychedelic Therapies, Submitting Recommendations to FDA
Barchart · 10/07 07:40
Weekly Report: what happened at CMND last week (0928-1002)?
Weekly Report · 10/05 09:33
Psychedelic: Psyence BioMed announces exclusive U.S. ibogaine license
TipRanks · 10/01 14:30
Clearmind Medicine Announces 1-For-8 Reverse Share Split, Effective October 5, 2026
Benzinga · 09/30 20:54
More
Webull provides a variety of real-time CMND stock news. You can receive the latest news about Clearmind Medici through multiple platforms. This information may help you make smarter investment decisions.
About CMND
Clearmind Medicine Inc. is a psychedelic pharmaceutical biotech company. The Company is focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorders. The Company researches and develops psychedelic-based compounds and attempts to commercialize them as regulated medicines, foods, or supplements. The Company’s intellectual portfolio consists of 19 patent families including 31 granted patents.